As a physician caring for patients in New Orleans, I see the consequences of America’s prescription drug affordability crisis every day. Many of my patients need essential medications like insulin, blood thinners, and inhalers to manage chronic conditions that impact…
The Government of Saint Lucia and the Indian Pharmacopoeia Commission (IPC) of India’s Ministry of Health and Family Welfare have signed a Memorandum of Understanding (MoU) on Pharmacopoeial Cooperation. Under the agreement, the two countries will work together on the…
Drugmaker Lupin said on Saturday that the US health regulator concluded an inspection at its Goa manufacturing facility with one observation. The inspection by the US Food and Drug Administration (USFDA) was conducted from October 19-23, 2026, Lupin said in a regulatory…
Keralam Health Minister K Muraleedharan on Friday defended the government’s decision to continue providing Natsmart, a lower-cost generic version of risdiplam manufactured by Indian pharmaceutical company Natco Pharma, to children suffering from spinal muscular atrophy (SMA). Amid a controversy over…
Stanford Health Care’s Janjri Desai, Pharm.D., says pharmacy should be treated as a clinical service line, not just a 340B financial workhorse. Pharmacy is still underused in enterprise-level decision-making as a strategic and clinical service line, according to Janjri Desai,…
Over the past few years, both Brazil and Venezuela have witnessed an increase in the production, growth, and acceptance of generic medicines in their respective healthcare systems. Brazil has one of the largest pharmaceutical markets in Latin America and is…
A recent opinion piece by members of the Alliance for Safe Biologic Medicines (ASBM), published in GaBI Journal [1], explores this shift which discards two decades of scientific consensus. Kennedy has characterized this distinction as unnecessary. However, the interchangeable standard was…
Exploring the barriers to biosimilar adoption in Chile Projections suggest that switching only four high-cost drugs could save more than US$26 million annually in Chile and expand patient access. However, despite having a biosimilar pathway established in 2014 (Norm N°170), no…
KUALA LUMPUR: Malaysia has proposed that the World Health Organisation's Western Pacific Regional Office (WPRO) urgently pilot a pooled procurement project for selected medicines to strengthen drug security across the region. "Regional diplomacy and solidarity today must be translated beyond…
pharmafile | September 11, 2026 | News story | | British Standards Institution, climate disruption, pharma, supply-chain risk Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to their supply chains to increase in the coming years, according to new research from…
Generic drugs and biosimilars: approvals, quality problems, patent expiries, competition and low-cost medicine programmes.
An article joins this feed when it matches these terms. Each one is also a search of its own.